There are 2789 resources available
Discussion LBA61 and 1172MO
Presenter: Alfredo Addeo
Session: Mini oral session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
Discussion 1505MO, 1506MO and 1507MO
Presenter: Christoph Benedikt Westphalen
Session: Mini oral session - Public policy
Resources:
Slides
Webcast
Discussion 1508MO, 1509MO and 1510MO_PR
Presenter: Dario Trapani
Session: Mini oral session - Public policy
Resources:
Slides
Webcast
1510MO_PR - European cancer patients’ perspectives on Immunotherapy
Presenter: Paraskevas Kosmidis
Session: Mini oral session - Public policy
Resources:
Abstract
Slides
Webcast
Introduction by the chair
Presenter: Florence Joly
Session: Should we test our patients in clinical practice with HRD? How and when?
Resources:
Slides
Webcast
Yes
Presenter: Isabelle Ray-Coquard
Session: Should we test our patients in clinical practice with HRD? How and when?
Resources:
Slides
Webcast
No
Presenter: Antonio Jose Gonzalez Martin
Session: Should we test our patients in clinical practice with HRD? How and when?
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: Florence Joly
Session: Should we test our patients in clinical practice with HRD? How and when?
Resources:
Slides
Webcast
Q&A
Presenter: Florence Joly
Session: Should we test our patients in clinical practice with HRD? How and when?
Resources:
Slides
Webcast
Full session recording
Presenter: Keith Kerr
Session: Janssen - Expanding horizons for the targeted management of EGFR-Positive NSCLC
Resources:
Webcast